Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Key proteins and potential drugs for treating alopecia areata were identified.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

The new nanocarriers improve how well water-insoluble drugs dissolve and allow for controlled drug release.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The TrichoConcept™ line is effective for personalized hair loss treatments.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Microneedle delivery of a special collagen shows promise for treating hair loss.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

The microneedle system effectively promotes hair growth for treating androgenic alopecia.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.

New compounds show promise as nonsteroidal treatments for hair loss.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

The new formulation improved the skin absorption of the drug Thiocolchicoside.

High-dose baricitinib improved severe alopecia areata in most patients without severe side effects.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Candida antigen is an effective and promising treatment for alopecia areata.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.